Linagliptin in the Management of Type 2 Diabetes Mellitus After Kidney Transplant.
Sign Up to like & getrecommendations! Published in 2021 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2021.07.035
Abstract: BACKGROUND The incidence and prevalence of end-stage renal disease (ESRD) is increasing. The most common cause of ESRD is diabetes mellitus (DM). Kidney transplantation offers better quality of life and survival for patients with ESRD.… read more here.
Keywords: kidney transplantation; study; diabetes mellitus; transplantation ... See more keywords
Sodium‐glucose cotransporter 2 inhibitors for treatment of diabetes mellitus after kidney transplantation
Sign Up to like & getrecommendations! Published in 2022 at "Clinical Transplantation"
DOI: 10.1111/ctr.14718
Abstract: Diabetes mellitus in kidney transplant recipients is a risk factor for cardiovascular events and premature death. Sodium‐glucose cotransporter 2 inhibitors (SGLT2i) are increasingly used in nontransplant populations to improve diabetes control and cardiovascular and renal… read more here.
Keywords: mellitus kidney; glucose cotransporter; diabetes mellitus; cotransporter inhibitors ... See more keywords